Home
University of Bergen
Arvid Rongve's picture

Arvid Rongve

Professor
Department of Clinical Medicine
  • E-mailArvid.Rongve@uib.no
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2024). Age of onset for increased dose-adjusted serum concentrations of antidepressants and association with sex and genotype: An observational study of 34,777 individuals. European Journal of Clinical Pharmacology.
  • Show author(s) (2023). Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease. Journal of Neuroinflammation. 16 pages.
  • Show author(s) (2023). Cerebrospinal fluid neurofilament light chain mediates age-associated lower learning and memory in healthy adults. Neurobiology of Aging. 39-47.
  • Show author(s) (2022). Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations. Journal of Alzheimer's Disease. 1533-1544.
  • Show author(s) (2022). New insights into the genetic etiology of Alzheimer's disease and related dementias. Nature Genetics. 412-436.
  • Show author(s) (2021). Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Molecular Psychiatry. 5797-5811.
  • Show author(s) (2021). Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores. Nature Communications. 1-16.
  • Show author(s) (2021). A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. Nature Genetics. 1276-1282.
  • Show author(s) (2020). The association between aspects of carer distress and time until nursing home admission in persons with Alzheimer’s disease and dementia with Lewy bodies. International Psychogeriatrics. 1-9.
  • Show author(s) (2020). Factors associated with self-rated health in a Norwegian population of older people participating in a preventive home visit program: a cross-sectional study. BMC Geriatrics. 1-12.
  • Show author(s) (2020). Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns. Journal of Cerebral Blood Flow and Metabolism. 1-13.
  • Show author(s) (2019). The association between specific neuropsychiatric disturbances in people with Alzheimer's disease and dementia with Lewy bodies and carer distress. International Journal of Geriatric Psychiatry. 1421-1428.
  • Show author(s) (2019). Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nature Genetics. 404-413.
  • Show author(s) (2019). GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study. Scientific Reports.
  • Show author(s) (2019). Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease. Translational Psychiatry. 1-10.
  • Show author(s) (2018). Risk assessment during preventive home visits among older people. Journal of Multidisciplinary Healthcare. 609-620.
  • Show author(s) (2018). Patterns of carer distress over time in mild dementia. International Journal of Geriatric Psychiatry. 987-993.
  • Show author(s) (2018). Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci. Scientific Reports. 8 pages.
  • Show author(s) (2018). Apathy is associated with faster global cognitive decline and early nursing home admission in dementia with Lewy bodies. Alzheimer's Research & Therapy. 1-8.
  • Show author(s) (2018). A longitudinal study of neurocognition in dementia with lewy bodies compared to Alzheimer's disease. Frontiers in Neurology. 1-7.
  • Show author(s) (2018). A 4-Day Mindfulness-Based Cognitive Behavioral Intervention Program for CFS/ME. An Open Study, With 1-Year Follow-Up. Frontiers in Psychiatry. 11 pages.
  • Show author(s) (2017). REM sleep behavior disorder is not associated with a more rapid cognitive decline in mild dementia. Frontiers in Neurology. 1-8.
  • Show author(s) (2017). Health team for the elderly: a feasibility study for preventive home visits. Primary Health Care Research and Development. 242-252.
  • Show author(s) (2017). Detecting at-risk Alzheimer's disease cases. Journal of Alzheimer's Disease. 97-105.
  • Show author(s) (2017). Accuracy of clinical diagnosis of dementia with lewy bodies versus neuropathology. Journal of Alzheimer's Disease. 1139-1152.
  • Show author(s) (2016). Potentially inappropriate medications and drug–drug interactions in home-dwelling people with mild dementia. International Journal of Geriatric Psychiatry. 183-192.
  • Show author(s) (2016). Neurocognitive deficits distinguishing mild dementia with Lewy bodies from mild Alzheimer's disease are associated with Parkinsonism. Journal of Alzheimer's Disease. 1277-1285.
  • Show author(s) (2016). Higher Frequency and Complexity of Sleep Disturbances in Dementia with Lewy Bodies as Compared to Alzheimer's Disease. Neurodegenerative Diseases. 152-160.
  • Show author(s) (2016). Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry. 1075-1083.
  • Show author(s) (2016). Association of Butyrylcholinesterase-K allele and Apolipoprotein E ε 4 allele with cognitive decline in dementia with lewy bodies and Alzheimer's disease. Journal of Alzheimer's Disease. 567-576.
  • Show author(s) (2016). A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer's disease. Alzheimer's Research & Therapy.
  • Show author(s) (2015). Polygenic overlap between C-reactive protein, plasma lipids, and Alzheimer disease. Circulation. 2061-2069.
  • Show author(s) (2014). Time until nursing home admission in people with mild dementia: Comparison of dementia with Lewy bodies and Alzheimer's dementia. International Journal of Geriatric Psychiatry. 392-398.
  • Show author(s) (2014). The use and costs of formal care in newly diagnosed dementia: A three-year prospective follow-up study. The American journal of geriatric psychiatry. 381-388.
  • Show author(s) (2014). Long-Term Mortality in a Cohort of Home-Dwelling Elderly with Mild Alzheimer's Disease and Lewy Body Dementia. Dementia and Geriatric Cognitive Disorders. 161-169.
  • Show author(s) (2014). Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort. Journal of Neurology, Neurosurgery and Psychiatry.
  • Show author(s) (2014). A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease. Alzheimer's Research & Therapy. 13 pages.
  • Show author(s) (2013). (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study. BMJ Open. 9 pages.
  • Show author(s) (2012). The frequency and correlates of anxiety in patients with first-time diagnosed mild dementia. International Psychogeriatrics. 1771-1778.
  • Show author(s) (2012). Parkinson's disease dementia and dementia with Lewy bodies – epidemiology, risk factors and biomarkers. Norsk Epidemiologi. 233-242.
  • Show author(s) (2012). Neuropsychiatric Symptoms in Mild Dementia with Lewy Bodies and Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 1-6.
  • Show author(s) (2012). Comparing Hippocampal Atrophy in Alzheimer's Dementia and Dementia with Lewy Bodies. Dementia and Geriatric Cognitive Disorders. 44-50.
  • Show author(s) (2011). Early and Presenting Symptoms of Dementia with Lewy Bodies. Dementia and Geriatric Cognitive Disorders. 202-208.
  • Show author(s) (2010). Frequency and Correlates of Caregiver-Reported Sleep Disturbances in a Sample of Persons with Early Dementia. Journal of The American Geriatrics Society. 480-486.
  • Show author(s) (2010). Core and Suggestive Symptoms of Dementia with Lewy Bodies Cluster in Persons with Mild Dementia. Dementia and Geriatric Cognitive Disorders. 317-324.
  • Show author(s) (2009). High Prevalence of Orthostatic Hypotension in Mild Dementia. Dementia and Geriatric Cognitive Disorders. 307-313.
  • Show author(s) (2008). Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 559-563.
  • Show author(s) (2008). Frequency and Case Identification of Dementia with Lewy Bodies Using the Revised Consensus Criteria. Dementia and Geriatric Cognitive Disorders. 445-452.
  • Show author(s) (2006). Management of Parkinson´s disease dementia: practical considerations. Drugs & Aging. 807-822.
Editorial
  • Show author(s) (2016). Non-Alzheimer dementias. Journal of Geriatric Psychiatry and Neurology. 247-248.
Doctoral dissertation
  • Show author(s) (2019). Demens med Lewylegemer: søvn, kognisjon og nevropatologi.
  • Show author(s) (2018). Er angst, apati og kognitiv sviktprofil assosiert med sykdomsprogresjon ved mild demens? Med hovedfokus på demens med Lewylegemer.
  • Show author(s) (2011). Dementia with Lewy Bodies. Identification, frequency and sleep disturbances. A cross-sectional dementia cohort study.
Academic chapter/article/Conference paper
  • Show author(s) (2020). The Lewy body dementias: Dementia with Lewy bodies and Parkinson’s disease dementia.
  • Show author(s) (2014). Dementia in Parkinson's Disease.
  • Show author(s) (2013). Dementia in Parkinson's disease and dementia with Lewy bodies.
Abstract
  • Show author(s) (2019). The course of apathy in people with dementia. Alzheimer's & Dementia. P570-P570.
  • Show author(s) (2019). Genome wide Association study: identifying Genetic markers in apathy in People with Alzheimer's disease. Alzheimer's & Dementia. P286-P286.
  • Show author(s) (2009). The frequency of anxiety in patients with a first time diagnosis of mild dementia. The Journal of Nutrition, Health & Aging. 652-652.
  • Show author(s) (2009). Clinical Consequences of anxiety in mild Alzheimer's disease and Dementia with Lewy bodies. The Journal of Nutrition, Health & Aging. 652-652.
Poster
  • Show author(s) (2023). The ANeED Study: Ambroxol in New and Early Dementia with Lewy bodies – the updated status.
  • Show author(s) (2023). Cerebrospinal fluid neurofilament light chain mediates age-related decline in learning and memory in healthy adults.
  • Show author(s) (2017). PREVALENCE AND CO-MORBIDITY OF APATHY AND DEPRESSION IN ALZHEIMER’S DISEASE.
  • Show author(s) (2017). AN EVALUATION OF PREDICTORS AND COGNITIVE DECLINE ASSOCIATED WITH PERSISTENT AND TRANSIENT PSYCHOTIC SYMPTOMS IN ALZHEIMER’S DISEASE.
  • Show author(s) (2015). Male caregivers to persons diagnosed with Lewy Body Dementia have higher stress level than caregiver to persons diagnosed with Alzheimers Dementia.
  • Show author(s) (2014). Probable REM sleep behaviour disorder is prevalent in early stage dementia with Lewy bodies in Western Norway.
  • Show author(s) (2013). Anxiety symptoms in Dementia with Lewy Bodies and Alzheimer’s disease: Preliminary results from a four-year follow-up study.
  • Show author(s) (2010). Anxiety and neuropsychological functioning in patients with a first time diagnose of mild dementia.
Errata
  • Show author(s) (2023). Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417)). Nature Communications. 716.
  • Show author(s) (2022). Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (Translational Neurodegeneration, (2022), 11, 1, (24), 10.1186/s40035-022-00299-w). Translational Neurodegeneration.
  • Show author(s) (2022). Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease (Nature Genetics, (2021), 53, 9, (1276-1282), 10.1038/s41588-021-00921-z). Nature Genetics. 1062.
  • Show author(s) (2021). Correction to: Factors associated with self-rated health in a Norwegian population of older people participating in a preventive home visit program: a cross-sectional study. BMC Geriatrics.
  • Show author(s) (2021). Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease (Nature Genetics, (2021), 53, 9, (1276-1282), 10.1038/s41588-021-00921-z). Nature Genetics.
  • Show author(s) (2019). Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2). Scientific Reports.
Academic literature review
  • Show author(s) (2022). Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design. Alzheimer's & Dementia.
  • Show author(s) (2022). Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations. Translational Neurodegeneration. 1-18.
  • Show author(s) (2020). The Cognitive Profile of Mild Cognitive Impairment Due to Dementia With Lewy Bodies—An Updated Review. Frontiers in Aging Neuroscience. 1-7.
  • Show author(s) (2019). Survival time and differences between dementia with Lewy bodies and Alzheimer's disease following diagnosis: A meta-analysis of longitudinal studies. Ageing Research Reviews. 72-80.
  • Show author(s) (2017). The relationship of specific items on the Neuropsychiatric Inventory to caregiver burden in dementia: a systematic review. International Journal of Geriatric Psychiatry. 703-717.
  • Show author(s) (2016). Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study. BMJ Open. 7 pages.
  • Show author(s) (2013). Alzheimers sykdom og genetikk. Tidsskrift for Den norske legeforening. 1449-1452.
  • Show author(s) (2012). Psychosis in Parkinson's disease. Tidsskrift for Den norske legeforening. 155-158.
  • Show author(s) (2012). Clinical trials of dementia with lewy bodies and Parkinson’s Disease dementia. Current Neurology and Neuroscience Reports. 492-501.
  • Show author(s) (2006). Current perspectives in dementia with Lewy bodies. Journal of Aging and Health. 461-472.
Article in business/trade/industry journal
  • Show author(s) (2023). The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial. Frontiers in Aging Neuroscience. 10 pages.

More information in national current research information system (CRIStin)